LauraGutierrez QuicenoMD

Neurocritical Care

Neurologist Neurocritical Care Fellow

Dr. Gutierrez Quiceno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
University of Cincinnati Medical Center
3188 Bellevue Avenue
Cincinnati, OH 45219
Phone+1 732-828-3000

Laura Gutierrez Quiceno, MD, is a neurology specialist based in Cincinnati, OH, with a subspecialty in neurocritical care. She graduated in 2014 from Universidad CES. Dr. Gutierrez Quiceno has authored publications including "Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS" and "ER Stress Signaling Promotes the Survival of Cancer 'Persister Cells' Tolerant to EGFR Tyrosine Kinase Inhibitors," which have been cited 49 and 72 times, respectively.

PubMed

3 citations
Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.
Ariel Diaz, Paola Merino, Patrick McCann, Manuel A. Yepes, Laura G Quiceno
Journal of Cerebral Blood Flow and Metabolism. 2021-03-24
50 citations
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS
Shunsuke Kitajima, Hajime Asahina, Ting Chen, Sujuan Guo, Laura Gutierrez Quiceno
Cancer Cell. 2018-09-10
73 citations
ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase Inhibitors
Hideki Terai, Shunsuke Kitajima, Danielle S. Potter, Yusuke Matsui, Laura Gutierrez Quiceno
Cancer Research. 2017-01-01

University of Cincinnati Researchers Showcase Findings at the 2025 International Stroke ConferenceFebruary 5th, 2025
UC Experts Present Research at International Stroke Conference 2025February 5th, 2025